Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Albany Molecular Research Inc (NASDAQ:AMRI)

20.21
Delayed Data
As of 11:25am ET
 +0.25 / +1.25%
Today’s Change
13.73
Today|||52-Week Range
23.95
+24.14%
Year-to-Date
No recent news for Albany Molecular Research Inc.

Today’s Trading

Previous close19.96
Today’s open19.74
Day’s range19.74 - 20.23
Volume53,400
Average volume (3 months)437,921
Market cap$707.6M
Dividend yield--
Data as of 11:25am ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)-125.00%
Earnings growth (this year)+39.68%
Earnings growth (next 5 years)+8.00%
Revenue growth (last year)+12.17%
P/E ratioNM
Price/Sales1.86
Price/Book2.69

Competitors

 Today’s
change
Today’s
% change
KERXKeryx Biopharmaceuti...+0.20+3.23%
FLXNFlexion Therapeutics...+0.09+0.36%
SGMOSangamo BioSciences ...-0.04-0.52%
AMRNAmarin Corporation P...+0.04+1.91%
Data as of 11:41am ET, 08/28/2015

Financials

Next reporting dateNovember 10, 2015
EPS forecast (this quarter)$0.20
Annual revenue (last year)$276.6M
Annual profit (last year)-$3.3M
Net profit margin-1.19%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
William S. Marth
Chief Financial Officer, Treasurer &
Senior VP
Felicia Ladin
Corporate headquarters
Albany, New York

Forecasts

Partner Offers